Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Fat, fit, and leading the charge: the evolution of measuring high-density lipoprotein subpopulations.

Nambi V, Ballantyne CM.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2013-5. No abstract available.

2.

Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?

Nicholls SJ, Tuzcu EM, Nissen SE.

Curr Atheroscler Rep. 2007 Oct;9(4):266-73. Review.

PMID:
18173953
3.

Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.

Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, Dahlb├Ąck B, Nielsen LB.

J Biol Chem. 2008 Jan 25;283(4):1839-47. Epub 2007 Nov 15.

4.

Nicotinic acid and other therapies for raising high-density lipoprotein.

Carlson LA.

Curr Opin Cardiol. 2006 Jul;21(4):336-44. Review.

PMID:
16755203
5.

Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2552-9. Epub 2006 Aug 31.

6.

The beneficial effects of high-density lipoprotein on adipocytes may relate to its anti-atherogenic properties.

Wu ZH, Zhao SP, Ye HJ.

Med Hypotheses. 2006;67(5):1195-9. Epub 2006 Jun 23.

PMID:
16797854
7.

[Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].

Kimura T, Okajima F, Murakami M.

Rinsho Byori. 2007 Apr;55(4):358-62. Review. Japanese.

PMID:
17511266
8.

The paraoxonase gene family and atherosclerosis.

Seo D, Goldschmidt-Clermont P.

Curr Atheroscler Rep. 2009 May;11(3):182-7. Review.

PMID:
19361349
9.

Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.

Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, Topic A, Zeljkovic A, Stefanovic A, Zunic G.

Eur J Clin Invest. 2007 Sep;37(9):715-23.

PMID:
17696961
10.

Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.

Barter PJ, Rye KA.

Curr Opin Lipidol. 2006 Aug;17(4):399-403. Review.

PMID:
16832163
11.

Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors.

Clark RW.

Curr Opin Pharmacol. 2006 Apr;6(2):162-8. Epub 2006 Feb 17. Review.

PMID:
16487747
12.

Serum sex hormones in premenopausal women with coronary heart disease.

Mohamad MJ, Karayyem M, Mohammad MA, Al-Alami J, Al-Hader A.

Neuro Endocrinol Lett. 2006 Dec;27(6):758-62.

PMID:
17186999
13.

HDL function as a target of lipid-modifying therapy.

Watson KE, Ansell BJ, Watson AD, Fonarow GC.

Rev Cardiovasc Med. 2007 Winter;8(1):1-8. Review.

PMID:
17401296
14.

High-density lipoproteins, inflammation and oxidative stress.

Tabet F, Rye KA.

Clin Sci (Lond). 2009 Jan;116(2):87-98. doi: 10.1042/CS20080106. Review.

PMID:
19076062
15.

High-density lipoprotein: is it always atheroprotective?

Ansell BJ, Fonarow GC, Fogelman AM.

Curr Atheroscler Rep. 2006 Sep;8(5):405-11. Review.

PMID:
16901411
16.

Lipid metabolism: pleiotropic effects of high-density lipoproteins.

van Greevenbroek MM.

Curr Opin Lipidol. 2006 Jun;17(3):363-5. No abstract available.

PMID:
16680041
17.
18.

Serum amyloid A: the "other" inflammatory protein.

O'Brien KD, Chait A.

Curr Atheroscler Rep. 2006 Jan;8(1):62-8. Review.

PMID:
16455016
19.

The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study.

Isaacs A, Sayed-Tabatabaei FA, Hofman A, Oostra BA, Klungel OH, Maitland-Vander Zee AH, Stricker BH, Witteman JC, van Duijn CM.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):419-21.

PMID:
17568242
20.

Supplemental Content

Support Center